Terms: = Breast cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Prognosis
31 results:
1. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract] [Full Text] [Related]
3. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
Sahin I; Saat H
Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
[No Abstract] [Full Text] [Related]
4. Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer.
Silvestri M; Dugo M; Vismara M; De Cecco L; Lanzoni D; Vingiani A; Folli S; De Santis MC; de Braud F; Pruneri G; Di Cosimo S; Cappelletti V
Sci Rep; 2022 Jan; 12(1):1470. PubMed ID: 35087134
[TBL] [Abstract] [Full Text] [Related]
5. Mutation of the PTCH1 gene predicts recurrence of breast cancer.
Wang CY; Chang YC; Kuo YL; Lee KT; Chen PS; Cheung CHA; Chang CP; Phan NN; Shen MR; Hsu HP
Sci Rep; 2019 Nov; 9(1):16359. PubMed ID: 31704974
[TBL] [Abstract] [Full Text] [Related]
6. A review on role of ATM gene in hereditary transfer of colorectal cancer.
Sriramulu S; Ramachandran M; Subramanian S; Kannan R; Gopinath M; Sollano J; Bissi L; Banerjee A; Marotta F; Pathak S
Acta Biomed; 2019 Jan; 89(4):463-469. PubMed ID: 30657113
[TBL] [Abstract] [Full Text] [Related]
7. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
Panagopoulou M; Karaglani M; Balgkouranidou I; Biziota E; Koukaki T; Karamitrousis E; Nena E; Tsamardinos I; Kolios G; Lianidou E; Kakolyris S; Chatzaki E
Oncogene; 2019 May; 38(18):3387-3401. PubMed ID: 30643192
[TBL] [Abstract] [Full Text] [Related]
8. Hypomethylation of mismatch repair genes MLH1 and msh2 is associated with chemotolerance of breast carcinoma: Clinical significance.
Dasgupta H; Islam S; Alam N; Roy A; Roychoudhury S; Panda CK
J Surg Oncol; 2019 Jan; 119(1):88-100. PubMed ID: 30481381
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients.
Omarini C; Bettelli S; Caprera C; Manfredini S; Caggia F; Guaitoli G; Moscetti L; Toss A; Cortesi L; Kaleci S; Maiorana A; Cascinu S; Conte PF; Piacentini F
Cancer Biol Ther; 2018; 19(10):879-886. PubMed ID: 30067438
[TBL] [Abstract] [Full Text] [Related]
10. Radiogenic angiosarcoma of the breast: case report and systematic review of the literature.
Dogan A; Kern P; Schultheis B; Häusler G; Rezniczek GA; Tempfer CB
BMC Cancer; 2018 Apr; 18(1):463. PubMed ID: 29690864
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathologic Characteristics of Endometrial cancer in Lynch Syndrome: A French Multicenter Study.
Rossi L; Le Frere-Belda MA; Laurent-Puig P; Buecher B; De Pauw A; Stoppa-Lyonnet D; Canlorbe G; Caron O; Borghese B; Colas C; Delhomelle H; Chabbert-Buffet N; Grandjouan S; Lecuru F; Bats AS
Int J Gynecol Cancer; 2017 Jun; 27(5):953-960. PubMed ID: 28525912
[TBL] [Abstract] [Full Text] [Related]
12. Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of breast cancer Based on TCGA Database.
Liu C; Chang H; Li XH; Qi YF; Wang JO; Zhang Y; Yang XH
J Cell Biochem; 2017 Dec; 118(12):4728-4734. PubMed ID: 28513990
[TBL] [Abstract] [Full Text] [Related]
13. [Specificities of carcinomas in adolescents and young adults].
Fresneau B; Dourthe ME; Jouin A; Laurence V; de Lambert G; Colas C; Coret M; Laprie A; Rebours C; Orbach D; Demoor-Goldschmidt C
Bull Cancer; 2017 Mar; 104(3):267-280. PubMed ID: 27989630
[TBL] [Abstract] [Full Text] [Related]
14. Identification of MicroRNAs as breast cancer prognosis Markers through the cancer Genome Atlas.
Chang JT; Wang F; Chapin W; Huang RS
PLoS One; 2016; 11(12):e0168284. PubMed ID: 27959953
[TBL] [Abstract] [Full Text] [Related]
15. [Molecular Pathogenesis of Colorectal cancer].
Král J; Slyšková J; Vodička P; Špičák J
Klin Onkol; 2016; 29(6):419-427. PubMed ID: 27951718
[TBL] [Abstract] [Full Text] [Related]
16. The genetic prediction of risk for gynecologic cancers.
Randall LM; Pothuri B
Gynecol Oncol; 2016 Apr; 141(1):10-6. PubMed ID: 27016223
[TBL] [Abstract] [Full Text] [Related]
17. Microsatellite Instability as a Biomarker for PD-1 Blockade.
Dudley JC; Lin MT; Le DT; Eshleman JR
Clin Cancer Res; 2016 Feb; 22(4):813-20. PubMed ID: 26880610
[TBL] [Abstract] [Full Text] [Related]
18. A seven-gene CpG-island methylation panel predicts breast cancer progression.
Li Y; Melnikov AA; Levenson V; Guerra E; Simeone P; Alberti S; Deng Y
BMC Cancer; 2015 May; 15():417. PubMed ID: 25986046
[TBL] [Abstract] [Full Text] [Related]
19. TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genes.
Liu L; Zhou W; Cheng CT; Ren X; Somlo G; Fong MY; Chin AR; Li H; Yu Y; Xu Y; O'Connor ST; O'Connor TR; Ann DK; Stark JM; Wang SE
Mol Cancer Res; 2014 Nov; 12(11):1597-609. PubMed ID: 25103497
[TBL] [Abstract] [Full Text] [Related]
20. DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.
Santarpia L; Iwamoto T; Di Leo A; Hayashi N; Bottai G; Stampfer M; André F; Turner NC; Symmans WF; Hortobágyi GN; Pusztai L; Bianchini G
Oncologist; 2013; 18(10):1063-73. PubMed ID: 24072219
[TBL] [Abstract] [Full Text] [Related]
[Next]
